Vitamin K Antagonist Pharmacology, Pharmacotherapy and Pharmacogenomics

In this knowledge-based continuing pharmacy education activity Mary Jane Mattern, PharmD, CACP discusses the pharmacology, pharmacotherapy and pharmacogenomics of vitamin K antagonist anticoagulants.

Target Audience

Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy.
This activity is not accredited for technicians.

Learning Objectives

At the conclusion of the activity, pharmacists will be able to:

  • Discuss the pharmacology of the vitamin K antagonist
  • Discuss the indications and contraindications for the vitamin K antagonists
  • Discuss the role genetics plays in the dosing of warfarin
  • Discuss the utility of how genetic testing will affect initial dosing of warfarin

Activity Faculty

Mary Jane Mattern, PharmD, CACP
Pharmacist, William W. Backus Hospital, Norwich, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Mary Jane Mattern, PharmD, CACP has no actual or potential conflicts of interest associated with this presentation.

Program Fees

Click on the registration link to register for this activity.  The cost is $15.00 if registering separately or 13 activities for $120.00 if bundling.  See registration site for details.

Grant Funding

There is no grant funding for this activity

ACPE logoThe University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  1 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-19-021-H01-P).  Credits will be uploaded electronically to CPE Monitor within 72 hours of completing the activity

Initial release date:  June 1, 2019
Planned expiration date:  May 31, 2022

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.